DK0413329T3 - 5-methyl-isoxazol-4-carboxylsyreanilider og 2-hydroxyethyliden-cyaneddikesyreanilider til behandling af øjensygdomme - Google Patents

5-methyl-isoxazol-4-carboxylsyreanilider og 2-hydroxyethyliden-cyaneddikesyreanilider til behandling af øjensygdomme

Info

Publication number
DK0413329T3
DK0413329T3 DK90115691.9T DK90115691T DK0413329T3 DK 0413329 T3 DK0413329 T3 DK 0413329T3 DK 90115691 T DK90115691 T DK 90115691T DK 0413329 T3 DK0413329 T3 DK 0413329T3
Authority
DK
Denmark
Prior art keywords
anilides
hydroxyethylidene
isoxazole
methyl
carboxylic acid
Prior art date
Application number
DK90115691.9T
Other languages
English (en)
Inventor
Stella M Robertson
Laura Smith Lang
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Application granted granted Critical
Publication of DK0413329T3 publication Critical patent/DK0413329T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90115691.9T 1989-08-18 1990-08-16 5-methyl-isoxazol-4-carboxylsyreanilider og 2-hydroxyethyliden-cyaneddikesyreanilider til behandling af øjensygdomme DK0413329T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39586089A 1989-08-18 1989-08-18

Publications (1)

Publication Number Publication Date
DK0413329T3 true DK0413329T3 (da) 1997-08-18

Family

ID=23564835

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90115691.9T DK0413329T3 (da) 1989-08-18 1990-08-16 5-methyl-isoxazol-4-carboxylsyreanilider og 2-hydroxyethyliden-cyaneddikesyreanilider til behandling af øjensygdomme

Country Status (15)

Country Link
EP (1) EP0413329B1 (da)
JP (1) JP3131693B2 (da)
KR (1) KR100192745B1 (da)
AT (1) ATE148628T1 (da)
AU (1) AU633346B2 (da)
CA (1) CA2023560C (da)
DD (1) DD297328A5 (da)
DE (1) DE69029884T2 (da)
DK (1) DK0413329T3 (da)
ES (1) ES2099700T3 (da)
HU (1) HU215959B (da)
IE (1) IE902978A1 (da)
IL (1) IL95412A (da)
TW (1) TW287948B (da)
ZA (1) ZA906544B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ244814A (en) * 1991-10-23 1994-06-27 Hoechst Ag N-phenyl-2-cyano-3-hydroxycrotonamide derivatives and pharmaceutical compositions
TW314467B (da) * 1993-03-31 1997-09-01 Hoechst Ag
US5610173A (en) * 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
US6335356B1 (en) 1994-01-07 2002-01-01 Sugen, Inc. Method of treating a patient by parenteral administration of a lipophilic compound
NZ293691A (en) * 1994-10-17 1999-07-29 Hoechst Japan Use of a medicament containing an anilide compound for treatment of type i allergic diseases
US5721277A (en) * 1995-04-21 1998-02-24 Sugen, Inc. Compounds and methods for inhibiting hyper-proliferative cell growth
US6331555B1 (en) 1995-06-01 2001-12-18 University Of California Treatment of platelet derived growth factor related disorders such as cancers
US6011051A (en) * 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
DE102006017896A1 (de) † 2006-04-13 2007-10-25 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Leflunomid enthaltende pharmazeutische Zusammensetzungen
CA2947067C (en) 2014-05-08 2023-02-14 Panoptes Pharma Ges.M.B.H. Compounds for treating ophthalmic diseases and disorders
WO2023182871A1 (ko) * 2022-03-25 2023-09-28 바스테라 주식회사 3-페닐이속사졸 유도체 및 이를 유효성분으로 함유하는 안질환 예방 또는 치료용 약학 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL178596C (nl) 1975-06-05 1986-04-16 Hoechst Ag Werkwijze voor het bereiden van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor het bereiden van daarin als geneeskrachtige verbindingen te gebruiken 5-methylisoxazool-4-carbonzuuraniliden.
NL186239B (nl) 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2854439A1 (de) * 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
HU905064D0 (en) 1991-01-28
HUT59600A (en) 1992-06-29
IL95412A (en) 1996-01-31
IE902978A1 (en) 1991-02-27
EP0413329A3 (en) 1992-04-15
DD297328A5 (de) 1992-01-09
IL95412A0 (en) 1991-06-30
TW287948B (da) 1996-10-11
EP0413329B1 (en) 1997-02-05
DE69029884T2 (de) 1997-08-14
DE69029884D1 (de) 1997-03-20
KR910004193A (ko) 1991-03-28
CA2023560C (en) 2000-12-12
HU215959B (hu) 1999-03-29
JPH0390024A (ja) 1991-04-16
ATE148628T1 (de) 1997-02-15
CA2023560A1 (en) 1991-02-19
EP0413329A2 (en) 1991-02-20
ES2099700T3 (es) 1997-06-01
AU633346B2 (en) 1993-01-28
ZA906544B (en) 1991-06-26
KR100192745B1 (ko) 1999-06-15
AU6110490A (en) 1991-02-21
JP3131693B2 (ja) 2001-02-05

Similar Documents

Publication Publication Date Title
BR9007938A (pt) Metodo e aparelho o tratamento de glaucoma
DK0413329T3 (da) 5-methyl-isoxazol-4-carboxylsyreanilider og 2-hydroxyethyliden-cyaneddikesyreanilider til behandling af øjensygdomme
NO894296D0 (no) Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.
DE58906894D1 (de) Einrichtung zur diagnostik und behandlung von nasenerkrankungen.
DE68909902T2 (de) Blutbehandlungseinrichtung des Hohlfasertyps.
DK95091A (da) Anvendelse af acetyl-d-carnitin ved terapeutisk behandling af glaucoma
KR900701323A (ko) 신규한 녹내장 치료용 안과 제제
ATE113207T1 (de) Benzamid gegen kognitive erkrankungen.
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
DK472688A (da) Anvendelse af bezafibrat til behandling af diabetes
FR2599156B1 (fr) Iris fixe corrigeant la vue du myope et de l'hypermetrope
NO912545L (no) Nye 3,3'-ditiobis(propionsyrer) og estere derav samt fremgangsmaate for deres fremstilling
DK0537313T3 (da) Arylalkylestere af 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre med terapeutisk aktivitet
ATE129895T1 (de) Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.
KR920700044A (ko) 눈의 동공수축을 유도 및 방지하기 위한 방법 및 수단
ATA137186A (de) Einrichtung zur gesteuerten waermebehandlung von weichenteilen
DK305289A (da) Apparat til behandling af reumatiske sygdomme
DK164910C (da) Fremgangsmaade til fremstilling af n-(2,4-dimethylthien-3-yl)-n-(methoxyprop-2-yl)-chloracetamid og forbindelse til anvendelse ved fremgangsmaaden
BR6700414U (pt) Rebaixamento periferico de lentes oftalmicas divergentes e/ou negativas
ATE66811T1 (de) Anwendung von n-((1-aethyl-2-pyrrolidinyl)methyl>methoxy-5-sulfamoylbenzamid zur sterilitaetsbehandlung.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
DK169087D0 (da) Praeparat til prophylakse og behandling af svinesygdomme
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
NO912528D0 (no) Behandling av sykdommer forbundet med jodmangel.
NO900671L (no) Innretning for diagnostering og behandling av nesesykdommer.